The PACS Group, Inc. (NYSE: PACS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a healthcare holding company in the post-acute care and medical care facilities space, PACS uses SEC reports to describe its facility portfolio, credit arrangements, governance, and risk profile.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of PACS Group’s operations, financial condition, and risk factors. These filings also provide context on the company’s role as a holding company, the structure of its independent operating subsidiaries, and the separation between licensed healthcare providers and non-provider entities. AI-generated highlights can point out key sections on post-acute care operations, use of credit facilities, and lease obligations.
Current reports on Form 8-K are particularly important for PACS, given its history of restatements, credit agreement amendments, and NYSE listing updates. Recent 8-K filings have addressed topics such as forbearance and amendments under the company’s amended and restated credit agreement, events of default and related waivers, NYSE listing extensions tied to delayed SEC filings, and the completion of an independent Audit Committee investigation and related restatements. AI summaries can help users quickly understand the implications of these events.
Users can also access proxy materials such as the Definitive Proxy Statement on Schedule 14A, which outlines matters presented to stockholders at the annual meeting, including director elections, auditor ratification, and advisory votes on executive compensation. In addition, the filings page provides real-time updates from EDGAR and convenient access to other forms, such as notifications of late filings on Form 12b-25. Together, these documents offer a comprehensive view of PACS Group’s regulatory history, governance decisions, and financial reporting, with AI tools available to simplify and explain complex disclosures.
PACS Group, Inc. insider activity: Co-Founder, CEO and Chairman Murray Jason Hulse reported a tax-related share withholding tied to vested restricted stock units. On 01/15/2026, 20,082 shares of common stock were withheld at a price of $39.49 per share to satisfy tax liabilities upon vesting of previously granted and reported restricted stock units, as described in the footnote. After this transaction, Hulse beneficially owned 54,847,135 shares of PACS Group common stock in direct form.
PACS Group, Inc. reported the results of its 2025 Annual Meeting of Stockholders held on December 19, 2025. A total of 149,241,113 shares, representing approximately 95.29% of the company’s common stock as of the November 10, 2025 record date, were represented online or by proxy, indicating very high shareholder participation.
Stockholders elected Class I directors Taylor Leavitt and Jacqueline Millard to serve until the 2028 annual meeting. They also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2025. In advisory votes, stockholders approved the company’s executive compensation and supported holding future say-on-pay votes every year, and the company plans to conduct these advisory votes annually unless the board later determines a different frequency is preferable.
PACS Group, Inc. reported that one of its directors received a grant of restricted stock units on December 19, 2025. The grant covers 4,399 RSUs, each representing the right to receive one share of PACS Group common stock when it vests, at a grant price of $0 per unit.
After this award, the director beneficially owns 10,837 shares of common stock in total. The RSUs will vest 100% on the earlier of December 19, 2026 or the date of the next annual meeting following the grant, as long as the director continues to serve the company.
PACS Group, Inc. reported an insider equity award for one of its directors. On 12/19/2025, the director acquired 4,399 restricted stock units (RSUs) of PACS Group common stock at a price of $0 per unit as reported on a Form 4. Each RSU entitles the holder to receive one share of common stock upon vesting.
The filing states that 100% of the RSUs will vest on the earlier of December 19, 2026 or the date of the next annual meeting following the grant date, provided the director continues to serve the company. Following this award, the director beneficially owns 27,138 shares of PACS Group common stock in total.
PACS Group, Inc. reported that one of its directors acquired additional equity through a new grant of restricted stock units. On December 19, 2025, the director received 4,399 RSUs of common stock at a price of $0 per unit, reflecting an equity award rather than an open‑market purchase. After this grant, the director beneficially owns 11,270 shares of PACS Group common stock in total.
The RSUs entitle the director to receive one share of common stock for each unit upon vesting. According to the award terms, 100% of the RSUs will vest on the earlier of December 19, 2026 or the date of the next annual meeting following the grant date, as long as the director continues to serve the company through that time.
PACS Group, Inc. reported an insider equity award for its Chief Accounting Officer on December 17, 2025. The officer acquired 32,500 shares of common stock tied to restricted stock units (RSUs) at a price of $0 and an additional 19,127 shares tied to RSUs, also at $0, as part of equity compensation.
The first RSU grant of 32,500 units will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to continued service. The second RSU grant of 19,127 units will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, also subject to the officer remaining in service. Following these transactions, the officer beneficially owns 378,218 shares of common stock directly.
PACS Group, Inc. reported that its Chief Legal Officer and Secretary received new equity awards in the form of restricted stock units (RSUs). On 12/17/2025, the officer acquired 100,000 shares of common stock at a price of $0 and an additional 21,855 shares at a price of $0, both reported as RSU grants. One RSU award vests in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, and the other vests in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, in each case subject to continued service. Following these transactions, the officer beneficially owns 877,691 shares of common stock directly.
PACS Group, Inc. reported an insider equity award for its President & Chief Operating Officer. On December 17, 2025, the executive received 175,000 shares of common stock in the form of restricted stock units (RSUs) at a price of $0. These RSUs vest in three substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, contingent on continued service.
On the same date, the executive also received an additional 41,018 RSUs at $0, vesting in three substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, also subject to continued service. Following these equity grants, the executive beneficially owns 2,725,680 shares of PACS Group common stock directly.
PACS Group, Inc. insider and co-founder, who serves as interim CFO and executive vice chair and is also a director and 10% owner, reported new equity awards in the form of restricted stock units (RSUs). On 12/17/2025, the insider was granted 150,000 RSUs of common stock at a price of $0, and a separate grant of 41,018 RSUs of common stock, also at $0. After these awards, the insider beneficially owned 54,817,217 shares of common stock.
The 150,000 RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to continued service. The 41,018 RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, also subject to continued service. Each RSU converts into one share of common stock upon vesting, so these grants increase the insider’s future equity exposure to PACS Group, Inc. over the multi‑year vesting period.
PACS Group, Inc. reported an insider equity award for its Co-Founder, CEO, Chairman and director, who is also a 10% owner. On December 17, 2025, the reporting person acquired 200,000 shares of common stock through restricted stock units and an additional 41,018 restricted stock units, both at a price of $0 per share.
The 200,000 RSUs vest in substantially equal annual installments on the first, second and third anniversaries of January 15, 2025, while the 41,018 RSUs vest in substantially equal annual installments on the first, second and third anniversaries of November 25, 2025, in each case subject to continued service. Following these transactions, the reporting person beneficially owns 54,867,217 shares of PACS Group common stock directly.